So we have it: three Ebola vaccines fast-tracked as the world braces for a fresh outbreak. British scientists, naturally, are at the vanguard. One might feel a swelling of national pride—or one might pause to consider the broader historical pattern.
Here is a disease that ravaged West Africa in 2014, killing thousands, exposing the fragility of public health systems across the developing world. Now, with the spectre of a new outbreak, our laboratories scramble once more. But why does it always take a crisis to galvanise action? Because we are a reactive civilisation, not a proactive one.
Consider the Victorians: they built sewers, improved sanitation, and tackled cholera not through vaccines but through engineering and civic discipline. We, by contrast, wait for the virus to arrive at our doorstep, then reach for the syringe. We have traded the slow, unglamorous work of prevention for the high-tech thrill of intervention. This is the mark of a decadent age: we prefer the dramatic cure to the boring prophylaxis.
And let us not forget the economic calculus. Who will pay for these vaccines? Poor nations, as ever, will rely on charity; the rich will hoard. The global health architecture mirrors the global wealth order: a fortress for the privileged, a gamble for the rest.
Yet I must concede: the science is impressive. British researchers have developed a new generation of vaccines that may offer longer protection and require no refrigeration. That is a genuine achievement, one that might have saved thousands of lives had it arrived a decade earlier. But better late than never—if it is not too late.
The real question is whether we will learn anything from this recurring drama. Every outbreak teaches us that disease is a product of ecological disruption, poverty, and broken systems. And every time we respond with a technological fix, as if the problem were merely a lack of biotechnology. We never address the root causes: deforestation, urban density without sanitation, the cynical exploitation of labour that keeps millions in unsanitary conditions.
So celebrate the vaccines, by all means. But do not mistake them for a solution. They are a sticky plaster on a gangrenous wound. We need a new global consensus on health, one that treats prevention as a public good, not a private luxury. I suspect we will get neither; we will simply await the next crisis, clutching our syringes.
That is the tragedy of our era: we have the means to save ourselves, but not the will. We are like Rome building aqueducts while the barbarians mass at the gates. We are clever, but not wise. And that, my friends, is why history will judge us harshly.
